GORAN MILJKOVIC: Open Payments
NPI 1053382416 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 25 payments from 12 companies in 2025. Trend: 2023 $76 · 2024 $884 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $120 |
| Gilead Sciences, Inc. | 5 | $85 |
| ViiV Healthcare Company | 3 | $66 |
| Insmed, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Cumberland Pharmaceuticals, Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: Arikayce, DALVANCE, REBYOTA, AVYCAZ, CABENUVA, DOVATO, VIBATIV, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
